|
1
|
Bonati LH, Ederle J, Dobson J, Engelter S,
Featherstone RL, Gaines PA, Beard JD, Venables GS, Markus HS,
Clifton A, et al: Length of carotid stenosis predicts
peri-procedural stroke or death and restenosis in patients
randomized to endovascular treatment or endarterectomy. Int J
Stroke. 9:3396–305. 2014. View Article : Google Scholar
|
|
2
|
Plummer C, Henderson RD, O'Sullivan JD and
Read SJ: Ischemic stroke and transient ischemic attack after head
and neck radiotherapy: A review. Stroke. 42:2410–2418. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schunck WH, Konkel A, Fischer R and
Weylandt KH: Therapeutic potential of omega-3 fatty acid-derived
epoxyeicosanoids in cardiovascular and inflammatory diseases.
Pharmacol Ther. 183:177–204. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iverson C, Bacong A, Liu S, Baumgartner S,
Lundstrom T, Oscarsson J and Miner JN: Omega-3-carboxylic acids
provide efficacious anti-inflammatory activity in models of
crystal-mediated inflammation. Sci Rep. 8:12172018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Trattner S, Ruyter B, Ostbye TK,
Kamal-Eldin A, Moazzami A, Pan J, Gjoen T, Brännäs E, Zlabek V and
Pickova J: Influence of dietary sesamin, a bioactive compound on
fatty acids and expression of some lipid regulating genes in Baltic
Atlantic salmon (Salmo salar L.) juveniles. Physiol Res.
60:125–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hirafuji M, Machida T, Tsunoda M, Miyamoto
A and Minami M: Docosahexaenoic acid potentiates interleukin-1beta
induction of nitric oxide synthase through mechanism involving
p44/42 MAPK activation in rat vascular smooth muscle cells. Br J
Pharmacol. 136:613–619. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Zhao F, Yu X, Lu X and Zheng G:
MicroRNA-155 modulates the proliferation of vascular smooth muscle
cells by targeting endothelial nitric oxide synthase. Int J Mol
Med. 35:1708–1714. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Delbosc S, Glorian M, Le Port AS, Bereziat
G, Andreani M and Limon I: The benefit of docosahexanoic acid on
the migration of vascular smooth muscle cells is partially
dependent on Notch regulation of MMP-2/-9. Am J Pathol.
172:1430–1440. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Terano T, Tanaka T, Tamura Y, Kitagawa M,
Higashi H, Saito Y and Hirai A: Eicosapentaenoic acid and
docosahexaenoic acid inhibit vascular smooth muscle cell
proliferation by inhibiting phosphorylation of Cdk2-cyclinE
complex. Biochem Biophys Res Commun. 254:502–506. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Newell M, Baker K, Postovit LM and Field
CJ: A critical review on the effect of docosahexaenoic acid (DHA)
on cancer cell cycle progression. Int J Mol Sci. 18:17842017.
View Article : Google Scholar
|
|
11
|
Rani K and Aung NY: Docosahexaenoic acid
inhibits vascular smooth muscle cell proliferation induced by
glucose variability. Open Biochem J. 11:56–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oono K, Takahashi K, Sukehara S, Kurosawa
H, Matsumura T, Taniguchi S and Ohta S: Inhibition of PC3 human
prostate cancer cell proliferation, invasion and migration by
eicosapentaenoic acid and docosahexaenoic acid. Mol Clin Oncol.
7:217–220. 2017.PubMed/NCBI
|
|
13
|
Geng L, Zhou W, Liu B, Wang X and Chen B:
DHA induces apoptosis of human malignant breast cancer tissues by
the TLR-4/PPAR-α pathways. Oncol Lett. 15:2967–2977.
2018.PubMed/NCBI
|
|
14
|
Sun Y, Wang K, Ye P, Wu J, Ren L, Zhang A,
Huang X, Deng P, Wu C, Yue Z, et al: MicroRNA-155 promotes the
directional migration of resident smooth muscle progenitor cells by
regulating monocyte chemoattractant protein 1 in transplant
arteriosclerosis. Arterioscler Thromb Vasc Biol. 36:1230–1239.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Kong D, Chen H, Liu S, Hu H, Wu T,
Wang J, Chen W, Ning Y, Li Y and Lu Z: miR-155 acts as an
anti-inflammatory factor in atherosclerosis-associated foam cell
formation by repressing calcium-regulated heat stable protein 1.
Sci Rep. 6:217892016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin C, Cheng L, Lu X, Xie T, Wu H and Wu
N: Elevated expression of miR-155 is associated with the
differentiation of CD8+ T cells in patients with HIV-1. Mol Med
Rep. 16:1584–1589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pacurari M and Tchounwou PB: Role of
MicroRNAs in renin-angiotensin-aldosterone system-mediated
cardiovascular inflammation and remodeling. Int J Inflam.
2015:1015272015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Izzard L, Dlugolenski D, Xia Y, McMahon M,
Middleton D, Tripp RA and Stambas J: Enhanced immunogenicity
following miR-155 incorporation into the influenza a virus genome.
Virus Res. 235:115–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heymans S, Corsten MF, Verhesen W, Carai
P, van Leeuwen RE, Custers K, Peters T, Hazebroek M, Stöger L,
Wijnands E, et al: Macrophage microRNA-155 promotes cardiac
hypertrophy and failure. Circulation. 128:1420–1432. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bhattacharya S, Chalk AM, Ng AJ, Martin
TJ, Zannettino AC, Purton LE, Lu J, Baker EK and Walkley CR:
Increased miR-155-5p and reduced miR-148a-3p contribute to the
suppression of osteosarcoma cell death. Oncogene. 35:5282–5294.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ji Y, Wrzesinski C, Yu Z, Hu J, Gautam S,
Hawk NV, Telford WG, Palmer DC, Franco Z, Sukumar M, et al: miR-155
augments CD8+ T-cell antitumor activity in lymphoreplete hosts by
enhancing responsiveness to homeostatic gammac cytokines. Proc Natl
Acad Sci USA. 112:476–481. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim S, Lee E, Jung J, Lee JW, Kim HJ, Kim
J, Yoo HJ, Lee HJ, Chae SY, Jeon SM, et al: microRNA-155 positively
regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast
cancer. Oncogene. 37:2982–2991. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang LX, Liu G, Zhu GF, Liu H, Guo RW, Qi
F and Zou JH: MicroRNA-155 inhibits angiotensin II-induced vascular
smooth muscle cell proliferation. J Renin Angiotensin Aldosterone
Syst. 15:109–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang G, Zhong L, Luo H and Wang S:
MicroRNA-155-3p promotes breast cancer progression through
down-regulating CADM1. Onco Targets Ther. 12:7993–8002. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang CR, Zhu HF and Zhu Y: Knockout of
microRNA-155 ameliorates the Th17/Th9 immune response and promotes
wound healing. Curr Med Sci. 39:954–964. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Knolle MD, Chin SB, Rana BMJ, Englezakis
A, Nakagawa R, Fallon PG, Git A and McKenzie ANJ: MicroRNA-155
protects group 2 innate lymphoid cells from apoptosis to promote
type-2 immunity. Front Immunol. 9:22322018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saleh M, Friedl A, Srivastava M, Soliman
H, Secombes CJ and El-Matbouli M: STAT3/SOCS3 axis contributes to
the outcome of salmonid whirling disease. PLoS One.
15:e02344792020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Oono K, Ohtake K, Watanabe C, Shiba S,
Sekiya T and Kasono K: Contribution of Pyk2 pathway and reactive
oxygen species (ROS) to the anti-cancer effects of eicosapentaenoic
acid (EPA) in PC3 prostate cancer cells. Lipids Health Dis.
19:152020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Watanabe Y and Tatsuno I: Prevention of
cardiovascular events with omega-3 polyunsaturated fatty acids and
the mechanism involved. J Atheroscler Thromb. 27:183–198. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Farina FM, Hall IF, Serio S, Zani S,
Climent M, Salvarani N, Carullo P, Civilini E, Condorelli G, Elia L
and Quintavalle M: miR-128-3p is a novel regulator of vascular
smooth muscle cell phenotypic switch and vascular diseases. Circ
Res. 126:e120–e135. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nakagawa I, Park HS, Yokoyama S, Wada T,
Yamada S, Motoyama Y, Kichikawa K and Nakase H: Pretreatment with
and ongoing use of omega-3 fatty acid ethyl esters reduce the
slow-flow phenomenon and prevent in-stent restenosis in patients
undergoing carotid artery stenting. J Vasc Surg. 66:122–129. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding X, Ge L, Yan A, Ding Y, Tao J, Liu Q
and Qiao C: Docosahexaenoic acid serving as sensitizing agents and
gefitinib resistance revertants in EGFR targeting treatment. Onco
Targets Ther. 12:10547–10558. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song TJ, Chang Y, Shin MJ, Heo JH and Kim
YJ: Low levels of plasma omega 3-polyunsaturated fatty acids are
associated with cerebral small vessel diseases in acute ischemic
stroke patients. Nutr Res. 35:368–374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morin C, Rousseau E, Blier PU and Fortin
S: Effect of docosahexaenoic acid monoacylglyceride on systemic
hypertension and cardiovascular dysfunction. Am J Physiol Heart
Circ Physiol. 309:H93–H102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yee D, Shah KM, Coles MC, Sharp TV and
Lagos D: MicroRNA-155 induction via TNF-α and IFN-γ suppresses
expression of programmed death ligand-1 (PD-L1) in human primary
cells. J Biol Chem. 292:20683–20693. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu L and Leng H, Shi X, Ji J, Fu J and
Leng H: miR-155 promotes cell proliferation and inhibits apoptosis
by PTEN signaling pathway in the psoriasis. Biomed Pharmacother.
90:524–530. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Seok HY, Chen J, Kataoka M, Huang ZP, Ding
J, Yan J, Hu X and Wang DZ: Loss of MicroRNA-155 protects the heart
from pathological cardiac hypertrophy. Circ Res. 114:1585–1595.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang J, Yu F, Jia X, Iwanowycz S, Wang Y,
Huang S, Ai W and Fan D: MicroRNA-155 deficiency enhances the
recruitment and functions of myeloid-derived suppressor cells in
tumor microenvironment and promotes solid tumor growth. Int J
Cancer. 136:E602–E613. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wan YC, Li T, Han YD, Zhang HY, Lin H and
Zhang B: MicroRNA-155 enhances the activation of Wnt/β-catenin
signaling in colorectal carcinoma by suppressing HMG-box
transcription factor 1. Mol Med Rep. 13:2221–2228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tu YX, Wang SB, Fu LQ, Li SS, Guo QP, Wu
Y, Mou XZ and Tong XM: Ovatodiolide targets chronic myeloid
leukemia stem cells by epigenetically upregulating hsa-miR-155,
suppressing the BCR-ABL fusion gene and dysregulating the
PI3K/AKT/mTOR pathway. Oncotarget. 9:3267–3277. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang L, Wang W, Li X, He S, Yao J, Wang
X, Zhang D and Sun X: MicroRNA-155 promotes tumor growth of human
hepatocellular carcinoma by targeting ARID2. Int J Oncol.
48:2425–2434. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu D, Han P, Gao C, Gao W, Yao X and Liu
S: microRNA-155 modulates hepatic stellate cell proliferation,
apoptosis, and cell cycle progression in rats with alcoholic
hepatitis via the MAPK signaling pathway through targeting SOCS1.
Front Pharmacol. 11:2702020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen L, Ming X, Li W, Bi M, Yan B, Wang X,
Yang P and Yang B: The microRNA-155 mediates hepatitis B virus
replication by reinforcing SOCS1 signalling-induced autophagy. Cell
Biochem Funct. 38:436–442. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ye J, Guo R, Shi Y, Qi F, Guo C and Yang
L: miR-155 regulated inflammation response by the SOCS1-STAT3-PDCD4
axis in Atherogenesis. Mediators Inflamm. 2016:80601822016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang Y, Yang L, Liang X and Zhu G:
MicroRNA-155 promotes atherosclerosis inflammation via targeting
SOCS1. Cell Physiol Biochem. 36:1371–1381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bouamar H, Jiang D, Wang L, Lin AP, Ortega
M and Aguiar RC: MicroRNA 155 control of p53 activity is context
dependent and mediated by Aicda and Socs1. Mol Cell Biol.
35:1329–1340. 2015. View Article : Google Scholar : PubMed/NCBI
|
